Literature DB >> 3094712

Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma.

C O'Farrelly, C Feighery, D S O'Briain, F Stevens, C E Connolly, C McCarthy, D G Weir.   

Abstract

Features that might distinguish uncomplicated coeliac disease from enteropathy associated T cell lymphoma were investigated. Of 76 patients with coeliac disease, 71 (93%) had raised levels of alpha gliadin antibody and all responded clinically and histologically to treatment with a gluten free diet. In contrast, none of 16 patients with enteropathy associated T cell lymphoma had raised levels of alpha gliadin antibody, and treatment with a gluten free diet resulted in histological improvement in one and transient clinical improvement in six patients. The ratio of women to men was 2.2:1 in the group with coeliac disease and 1:1.6 in the patients with enteropathy associated T cell lymphoma. Thus patients with enteropathy associated T cell lymphoma do not display a humoral immune response to wheat protein (alpha gliadin), rarely respond to a gluten free diet, and are often men. Patients with uncomplicated coeliac disease usually have raised levels of alpha gliadin antibody, always respond to a gluten free diet, and are frequently women. These findings suggest the presence of two separate forms of enteropathy: one is benign and sensitive to wheat protein whereas the other runs a malignant course.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094712      PMCID: PMC1341707          DOI: 10.1136/bmj.293.6552.908

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

Review 1.  Clinical and morphologic response to gluten withdrawal.

Authors:  J S Stewart
Journal:  Clin Gastroenterol       Date:  1974-01

2.  Coeliac disease. Introduction and definition.

Authors:  W T Cooke; P Asquith
Journal:  Clin Gastroenterol       Date:  1974-01

3.  Evaluation of a Behring laser-nephelometer prototype in the measurement of IgG, IgA and IgM.

Authors:  R Daigneault; D Lemieux
Journal:  Clin Biochem       Date:  1978-02       Impact factor: 3.281

4.  Malignant celiac syndrome. Report of two cases with malabsorption and microscopic foci of intestinal lymphoma.

Authors:  D O Hourihane; D G Weir
Journal:  Gastroenterology       Date:  1970-07       Impact factor: 22.682

5.  Immunophenotype analysis of malignant histiocytosis of the intestine.

Authors:  D M Salter; A S Krajewski; A E Dewar
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

6.  Cellular response to alpha-gliadin in untreated coeliac disease.

Authors:  C O'Farrelly; C Feighery; J F Greally; D G Weir
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

Review 7.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Authors:  P I Terasaki; D Bernoco; M S Park; G Ozturk; Y Iwaki
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

8.  Coeliac disease and malignancy.

Authors:  C M Swinson; G Slavin; E C Coles; C C Booth
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

9.  HLA type of patients with coeliac disease and malignancy in the west of Ireland.

Authors:  B R O'Driscoll; F M Stevens; T A O'Gorman; P Finnegan; J J McWeeney; M P Little; C E Connolly; C F McCarthy
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

10.  Intestinal lymphoma associated with malabsorption.

Authors:  P Isaacson; D H Wright
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

View more
  27 in total

1.  Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Authors:  Reem Z Sharaiha; Ben Lebwohl; Laura Reimers; Govind Bhagat; Peter H Green; Alfred I Neugut
Journal:  Cancer       Date:  2011-12-13       Impact factor: 6.860

Review 2.  Enteropathy-associated T cell lymphoma presenting with acute abdominal syndrome: a case report and review of literature.

Authors:  Yifan Yang; Sukhjeet S Batth; Mingyi Chen; Dariusz Borys; Ho Phan
Journal:  J Gastrointest Surg       Date:  2012-04-12       Impact factor: 3.452

3.  Enteropathy associated T cell lymphoma - a case report of an uncommon extranodal T cell lymphoma.

Authors:  Geetha V; Ranjini Kudva; Anna Joseph Amprayil
Journal:  J Clin Diagn Res       Date:  2014-10-20

4.  Changes in intraepithelial lymphocyte subpopulations in coeliac disease and enteropathy associated T cell lymphoma (malignant histiocytosis of the intestine).

Authors:  J Spencer; T T MacDonald; T C Diss; J A Walker-Smith; P J Ciclitira; P G Isaacson
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

Review 5.  Pathogenesis of Enteropathy-Associated T Cell Lymphoma.

Authors:  Udit Chander; Rebecca J Leeman-Neill; Govind Bhagat
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

6.  Histological changes associated with wheat protein antibodies in the absence of villous atrophy.

Authors:  C O'Farrelly; F Graeme-Cook; D O Hourihane; C Feighery; D G Weir
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

7.  Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum.

Authors:  M Lawler; P Humphries; C O'Farrelly; H Hoey; O Sheils; M Jeffers; D S O'Briain; D Kelleher
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

8.  Altered gastrointestinal immune response in sarcoidosis.

Authors:  P A McCormick; C Feighery; C Dolan; C O'Farrelly; P Kelliher; F Graeme-Cook; A Finch; K Ward; M X Fitzgerald; D P O'Donoghue
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

9.  Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.

Authors:  J Spencer; N Cerf-Bensussan; A Jarry; N Brousse; D Guy-Grand; A S Krajewski; P G Isaacson
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

10.  Risk of lymphoma in patients with dermatitis herpetiformis.

Authors:  B Sigurgeirsson; B A Agnarsson; B Lindelöf
Journal:  BMJ       Date:  1994-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.